Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19

Published:2005-08-23 Issue:6 Volume:5 Page:365-373
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Timm R,Kaiser R,Lötsch J,Heider U,Sezer O,Weisz K,Montemurro M,Roots I,Cascorbi I

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/6500330.pdf

Reference38 articles.

1. Hanel M, Kroger N, Sonnenberg S, Bornhauser M, Kruger W, Kroschinsky F et al. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma. Ann Hematol 2002; 81: 96–102.

2. Tam CS, Wolf MM, Januszewicz EH, Prince HM, Westerman D, Seymour JF . Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies. Cancer 2004; 100: 2181–2189.

3. Rodenhuis S . High-dose chemotherapy in breast cancer—interpretation of the randomized trials. Anticancer Drugs 2001; 12: 85–88.

4. Ben Ari ET . Dual purpose: some cancer therapies used to treat autoimmune diseases. J Natl Cancer Inst 2004; 96: 577–579.

5. Pendse S, Ginsburg E, Singh AK . Strategies for preservation of ovarian and testicular function after immunosuppression. Am J Kidney Dis 2004; 43: 772–781.

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug reactive metabolite-induced hepatotoxicity: a comprehensive review;Toxicology Mechanisms and Methods;2024-04

2. Роль полиморфных вариантов генов цитохромов Р450, а также генов GSTP1 и MDR1 в развитии токсических осложнений при проведении программной противоопухолевой лекарственной терапии у пациентов с классической лимфомой Ходжкина;Clinical Oncohematology;2024-04-01

3. Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy;Journal of Pharmaceutical Investigation;2023-12-01

4. Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens;Best Practice & Research Clinical Haematology;2023-06

5. Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy;Antioxidants & Redox Signaling;2023-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3